Arcutis Biotherapeutics, Inc. (ARQT)
Nasdaq: ARQT · CIK 0001787306 · United States
Every official Arcutis Biotherapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open ARQT filings
Arcutis Biotherapeutics, Inc. documents
- Arcutis Biotherapeutics, Inc. 10-K 2026ARQT 10-K 2026: annual report for fiscal 2026
- Arcutis Biotherapeutics, Inc. 10-K 2025ARQT 10-K 2025: annual report for fiscal 2025
- Arcutis Biotherapeutics, Inc. 10-K 2024ARQT 10-K 2024: annual report for fiscal 2024
- Arcutis Biotherapeutics, Inc. 10-K 2023ARQT 10-K 2023: annual report for fiscal 2023
- Arcutis Biotherapeutics, Inc. 10-K 2022ARQT 10-K 2022: annual report for fiscal 2022
- Arcutis Biotherapeutics, Inc. 10-Q 2026ARQT 10-Q 2026: quarterly report for fiscal 2026
- Arcutis Biotherapeutics, Inc. 10-Q 2025ARQT 10-Q 2025: quarterly report for fiscal 2025
- Arcutis Biotherapeutics, Inc. 10-Q 2024ARQT 10-Q 2024: quarterly report for fiscal 2024
- Arcutis Biotherapeutics, Inc. 10-Q 2023ARQT 10-Q 2023: quarterly report for fiscal 2023
- Arcutis Biotherapeutics, Inc. 10-Q 2022ARQT 10-Q 2022: quarterly report for fiscal 2022
- Arcutis Biotherapeutics, Inc. 8-K 2026ARQT 8-K 2026: current report for fiscal 2026
- Arcutis Biotherapeutics, Inc. 8-K 2025ARQT 8-K 2025: current report for fiscal 2025
- Arcutis Biotherapeutics, Inc. 8-K 2024ARQT 8-K 2024: current report for fiscal 2024
- Arcutis Biotherapeutics, Inc. 8-K 2023ARQT 8-K 2023: current report for fiscal 2023
- Arcutis Biotherapeutics, Inc. 8-K 2022ARQT 8-K 2022: current report for fiscal 2022
- Arcutis Biotherapeutics, Inc. DEF 14A 2026ARQT DEF 14A 2026: proxy statement for fiscal 2026
- Arcutis Biotherapeutics, Inc. DEF 14A 2025ARQT DEF 14A 2025: proxy statement for fiscal 2025
- Arcutis Biotherapeutics, Inc. DEF 14A 2024ARQT DEF 14A 2024: proxy statement for fiscal 2024
- Arcutis Biotherapeutics, Inc. DEF 14A 2023ARQT DEF 14A 2023: proxy statement for fiscal 2023
- Arcutis Biotherapeutics, Inc. DEF 14A 2022ARQT DEF 14A 2022: proxy statement for fiscal 2022
- Arcutis Biotherapeutics, Inc. Form 4 2026ARQT Form 4 2026: insider trading filing for fiscal 2026
- Arcutis Biotherapeutics, Inc. Form 4 2025ARQT Form 4 2025: insider trading filing for fiscal 2025
- Arcutis Biotherapeutics, Inc. Form 4 2024ARQT Form 4 2024: insider trading filing for fiscal 2024
- Arcutis Biotherapeutics, Inc. Form 4 2023ARQT Form 4 2023: insider trading filing for fiscal 2023
- Arcutis Biotherapeutics, Inc. Form 4 2022ARQT Form 4 2022: insider trading filing for fiscal 2022
- Arcutis Biotherapeutics, Inc. S-1 2026ARQT S-1 2026: registration statement for fiscal 2026
- Arcutis Biotherapeutics, Inc. S-1 2025ARQT S-1 2025: registration statement for fiscal 2025
- Arcutis Biotherapeutics, Inc. S-1 2024ARQT S-1 2024: registration statement for fiscal 2024
- Arcutis Biotherapeutics, Inc. S-1 2023ARQT S-1 2023: registration statement for fiscal 2023
- Arcutis Biotherapeutics, Inc. S-1 2022ARQT S-1 2022: registration statement for fiscal 2022
- Arcutis Biotherapeutics, Inc. 13F 2026ARQT 13F 2026: institutional holdings for fiscal 2026
- Arcutis Biotherapeutics, Inc. 13F 2025ARQT 13F 2025: institutional holdings for fiscal 2025
- Arcutis Biotherapeutics, Inc. 13F 2024ARQT 13F 2024: institutional holdings for fiscal 2024
- Arcutis Biotherapeutics, Inc. 13F 2023ARQT 13F 2023: institutional holdings for fiscal 2023
- Arcutis Biotherapeutics, Inc. 13F 2022ARQT 13F 2022: institutional holdings for fiscal 2022
More companies